Cord Blood Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationStem Cell TransplantationGraft vs Host DiseaseStem CellsTransplantation ConditioningTransplantation, AutologousHematologic NeoplasmsCytomegalovirus InfectionsRoseolovirus InfectionsHistocompatibility TestingAspergillosisBone Marrow TransplantationHematopoietic Stem CellsTreatment OutcomeCytomegalovirusFetal BloodTissue DonorsTransplantation ChimeraPeripheral Blood Stem Cell TransplantationRetrospective StudiesGraft SurvivalEmbryonic Stem CellsAdult Stem CellsKidney TransplantationRecurrenceImmunosuppressive AgentsBusulfanTransplantationGraft vs Leukemia EffectLiver TransplantationPluripotent Stem CellsLeukemiaMyeloablative AgonistsRemission InductionCell DifferentiationHistocompatibilityTime FactorsWhole-Body IrradiationVidarabineMesenchymal Stem Cell TransplantationGraft vs Tumor EffectHematopoietic Stem Cell MobilizationStem Cell NicheGraft RejectionImmunocompromised HostAntigens, CD34Leukemia, Myeloid, AcuteNeural Stem CellsInduced Pluripotent Stem CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMultiple MyelomaCombined Modality TherapyT-LymphocytesSurvival AnalysisHeart TransplantationMesenchymal Stromal CellsLymphocyte DepletionTransplantation ImmunologySurvival RateCells, CulturedSalvage TherapyMultipotent Stem CellsPrecursor Cell Lymphoblastic Leukemia-LymphomaOpportunistic InfectionsSpinal CordImmunosuppressionSiblingsAnemia, AplasticStem Cell FactorVirus ActivationBone Marrow CellsAcute DiseaseChimerismLung TransplantationMycosesFlow CytometryMyelodysplastic SyndromesCell TransplantationHematologic DiseasesHepatic Veno-Occlusive DiseaseHLA AntigensFollow-Up StudiesAntilymphocyte SerumLymphocyte TransfusionCell LineageCyclophosphamideDisease-Free SurvivalMinor Histocompatibility AntigensCell SeparationAntineoplastic Combined Chemotherapy ProtocolsMelphalanTransplantation, IsogeneicMice, Inbred C57BLCyclosporineCell ProliferationGanciclovirOrgan TransplantationHerpesvirus 6, Human